Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03040726
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:31.443600+00:00
Published At
2023-10-17T00:00:00+00:00
Record Updated At
2023-10-17
Results Posted At
2023-10-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Malignant Neoplasm", "Nausea", "Vomiting"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-17"
protocolSection.identificationModule.nctId
"NCT03040726"
protocolSection.identificationModule.officialTitle
"Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer Patients"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-10-17"

Study condition terms

  • Malignant Neoplasm (protocolSection.conditionsModule.conditions)
  • Nausea (protocolSection.conditionsModule.conditions)
  • Vomiting (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.